Thomas Beimers
Partner
Minneapolis
Washington, D.C.

Biography
Health care and life sciences industry clients withchallenging regulatory compliance problems, especiallyFalse Claims Act (FCA) investigations, turn to Tom
Beimers. Tom's service with the Department of Healthand Human Services Office of Inspector General (HHSOIG), combined with extensive private practice litigationand investigations experience, helps clients navigate allphases of complex regulatory matters.
Tom enjoys advising health care and life sciences
clients on regulatory compliance and health care fraud
and abuse matters. He regularly provides strategic
analysis regarding business arrangements andproposed transactions, including customer contracts,
discount and rebate arrangements, business courtesies,
consulting agreements, marketing programs, aggregate
spend reporting, and charitable programs. Tom's
experience with OIG and as an advisor to multiple life
sciences and health care companies allows him tobenchmark against industry standard practices andagency perspectives. This broad vantage point helps
ensure that clients are simultaneously able to meetlegal requirements and engage in competitive businessarrangements.
Tom had a distinguished career in government before
joining his previous international law firm. He served as
senior counsel for HHS OIG, where he helped resolve
major FCA cases involving Anti-Kickback Statuteviolations, off-label marketing, drug pricing, andPhone+1 612 402 3025 (Minneapolis)+1 202 637 5600 (Washington, D.C.)

Fax+1 612 402 3001 (Minneapolis)+1 202 637 5910 (Washington, D.C.)

Emailthomas.beimers@hoganlovells.com

Languages
EnglishPractices
HealthMedical Device and Technology
Regulatory
Pharmaceuticals and Biotechnology
Regulatory
Investigations, White Collar, andFraudIndustries
Life Sciences and Health Care

Medicaid and Medicare reimbursement, and served asa monitor for manufacturers and providers operating
under Corporate Integrity Agreements. He was also aSpecial Assistant U.S. Attorney, serving as a prosecutor
for the Department of Justice's Medicare Fraud Strike
Force in Detroit, Michigan. In that role, he oversaw allphases of investigations into violations of criminal
health care fraud laws, including jury trials.

Areas of focus

Tom is a frequent national speaker and author on
topics related to health care fraud and abuse, whitecollar criminal defense, and compliance matters.

J.D., University of Minnesota Law
School, magna cum laude, 1998
B.A., Macalester College, Phi Beta
Kappa, 1991

False Claims Act and Qui Tam

Education and admissions
Education

Representative experience
Lead defense counsel on numerous False Claims Act
matters involving allegations of Anti-Kickback Statuteand fraud violations in medical device industry.
Routinely handles internal investigations involving
matters such as fraud allegations, Anti-Kickback Statutecompliance, marketing and promotion practices, drug
pricing, and reimbursement issues.
Served as interim chief compliance officer for global
medical device manufacturer.
Advise clients on compliance with aggregate spend
reporting required under CMS Open Payments Law(Physician Payments Sunshine Act).
Advise manufacturer and provider clients onnegotiation and implementation of Corporate Integrity
Agreements.
Former prosecutor with joint DOJ/HHS Medicare Fraud
Strike Force.
While at OIG, served as government monitor forseveral pharmaceutical industry and provider
Corporate Integrity Agreements.

Latest thinking and events
Insights and Analysis
New DOJ Whistleblower Program incentivizes
reporting of health care fraud in private payer
claimsMemberships
American Health Law Association
Health Care Compliance Association
Federal Bar Association

Bar admissions andqualifications
Minnesota
District of Columbia

Court admissions
U.S. Supreme Court
U.S. Court of Appeals, District ofColumbia Circuit
U.S. Court of Appeals, Eighth Circuit
U.S. Court of Appeals, Fifth Circuit
U.S. Court of Appeals, Fourth Circuit
U.S. Court of Appeals, Ninth Circuit

NewsProviders & payers sign U.S. pledge to develop AI
responsibly, as HHS finalizes Health IT ruleNews
OIG’s first-ever General Compliance ProgramGuidance covering all health care parties released
NewsSupreme Court’s Schutte decision: the meaning ofknowledge remains elusive
NewsCMS proposes significant changes to Medicaid
Drug Rebate Program
News
Oral arguments suggest hesitancy from SCOTUS toagree with the Seventh Circuit on SuperValu FCAcase